These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. Miller G; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP J Immunol; 2003 Apr; 170(7):3554-64. PubMed ID: 12646617 [TBL] [Abstract][Full Text] [Related]
4. LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism. Fallarino F; Pallotta MT; Matino D; Gargaro M; Orabona C; Vacca C; Mondanelli G; Allegrucci M; Boon L; Romani R; Talesa VN; Puccetti P; Grohmann U Immunobiology; 2015 Feb; 220(2):315-21. PubMed ID: 25278421 [TBL] [Abstract][Full Text] [Related]
5. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus. Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056 [TBL] [Abstract][Full Text] [Related]
6. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis. Li CC; Munitic I; Mittelstadt PR; Castro E; Ashwell JD PLoS Biol; 2015 Oct; 13(10):e1002269. PubMed ID: 26440998 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. Bohannon J; Cui W; Cox R; Przkora R; Sherwood E; Toliver-Kinsky T J Immunol; 2008 Mar; 180(5):3038-48. PubMed ID: 18292526 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiles in Children With Septic Shock With or Without Immunoparalysis. Snyder A; Jedreski K; Fitch J; Wijeratne S; Wetzel A; Hensley J; Flowers M; Bline K; Hall MW; Muszynski JA Front Immunol; 2021; 12():733834. PubMed ID: 34659221 [TBL] [Abstract][Full Text] [Related]
10. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. Doxsee CL; Riter TR; Reiter MJ; Gibson SJ; Vasilakos JP; Kedl RM J Immunol; 2003 Aug; 171(3):1156-63. PubMed ID: 12874201 [TBL] [Abstract][Full Text] [Related]
15. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Karp CL; Wysocka M; Ma X; Marovich M; Factor RE; Nutman T; Armant M; Wahl L; Cuomo P; Trinchieri G Eur J Immunol; 1998 Oct; 28(10):3128-36. PubMed ID: 9808181 [TBL] [Abstract][Full Text] [Related]
16. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo. Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026 [TBL] [Abstract][Full Text] [Related]